Skip to main content

Advertisement

ADVERTISEMENT

News

News
05/24/2022
Researchers at Keck School of Medicine of USC move experimental drug closer to approval for clinical use.
Researchers at Keck School of Medicine of USC move experimental drug closer to approval for clinical use.
Researchers at Keck School of...
05/24/2022
Vascular Disease Management

Advertisement

News
05/24/2022
May 24, 2022, TAMPA, Fla.– Upstream Peripheral Technologies announced today that it has partnered with Red One Medical for the introduction of the GoBack® Crossing and Reentry Catheter to the VA Health System. The partnership will allow...
May 24, 2022, TAMPA, Fla.– Upstream Peripheral Technologies announced today that it has partnered with Red One Medical for the introduction of the GoBack® Crossing and Reentry Catheter to the VA Health System. The partnership will allow...
May 24, 2022, TAMPA, Fla.–...
05/24/2022
Cath Lab Digest
News
05/24/2022
One in eight people who were hospitalized with COVID-19 between May 2020 and March 2021 were later diagnosed with myocarditis, or heart inflammation, according to major new research into the clinical long-term effects of COVID-19.
One in eight people who were hospitalized with COVID-19 between May 2020 and March 2021 were later diagnosed with myocarditis, or heart inflammation, according to major new research into the clinical long-term effects of COVID-19.
One in eight people who were...
05/24/2022
Cath Lab Digest
News
05/20/2022
MHIF is coordinating center for PROGRESS-CTO registry, which began in 2012 under the leadership of Dr. Emmanouil Brilakis, to advance care for CTO patients around the world
MHIF is coordinating center for PROGRESS-CTO registry, which began in 2012 under the leadership of Dr. Emmanouil Brilakis, to advance care for CTO patients around the world
MHIF is coordinating center for...
05/20/2022
Cath Lab Digest

Advertisement

News
05/19/2022
New financing will further support the development of FastWave’s proprietary intravascular lithotripsy systems.
New financing will further support the development of FastWave’s proprietary intravascular lithotripsy systems.
New financing will further...
05/19/2022
Cath Lab Digest
News
05/19/2022
Findings Hold Promise for Female Patients with Calcified Coronary Artery Disease Who Previously Suffered Worse Safety Outcomes than Male Patients Undergoing Atherectomy
Findings Hold Promise for Female Patients with Calcified Coronary Artery Disease Who Previously Suffered Worse Safety Outcomes than Male Patients Undergoing Atherectomy
Findings Hold Promise for Female...
05/19/2022
Cath Lab Digest
News
05/19/2022
Randomized Disrupt PAD III Study Finds Superior Vessel Preparation Leads to Excellent Long-Term Outcomes and Preserved Future Treatment Options
Randomized Disrupt PAD III Study Finds Superior Vessel Preparation Leads to Excellent Long-Term Outcomes and Preserved Future Treatment Options
Randomized Disrupt PAD III Study...
05/19/2022
Vascular Disease Management

Advertisement

News
05/18/2022
Funds will support clinical development and regulatory approval of fully absorbable percutaneous closure devices for large-bore vessels
Funds will support clinical development and regulatory approval of fully absorbable percutaneous closure devices for large-bore vessels
Funds will support clinical...
05/18/2022
Cath Lab Digest
News
05/02/2022
May 2, 2022 — A new study suggests that reducing daily sedentary time can have a positive effect on the risk factors of lifestyle diseases already in three months. Spending just one hour less sitting daily and increasing light physical...
May 2, 2022 — A new study suggests that reducing daily sedentary time can have a positive effect on the risk factors of lifestyle diseases already in three months. Spending just one hour less sitting daily and increasing light physical...
May 2, 2022 — A new study...
05/02/2022
Cath Lab Digest
News
04/27/2022
April 27, 2022 — Medtronic announced new randomized controlled data demonstrating the sustained and superior performance of IN.PACT AV drug coated balloon (DCB) compared to percutaneous transluminal angioplasty (PTA)  through 36 months,...
April 27, 2022 — Medtronic announced new randomized controlled data demonstrating the sustained and superior performance of IN.PACT AV drug coated balloon (DCB) compared to percutaneous transluminal angioplasty (PTA)  through 36 months,...
April 27, 2022 — Medtronic...
04/27/2022
Cath Lab Digest

Advertisement

Advertisement